| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/19/2011 | EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2011 | EP1330442B1 Phthalazinone derivatives |
| 01/19/2011 | EP1067123B1 Nitrogenous heterocyclic compounds |
| 01/19/2011 | CN1929847B Fasudil-containing preparation and method of improving stability thereof |
| 01/19/2011 | CN1816543B Indole derivatives with apoptosis-inducing effect |
| 01/19/2011 | CN101952280A Bicyclic heterocyclic derivative |
| 01/19/2011 | CN101952277A Fluorescent, heterocyclic annellated perylene |
| 01/19/2011 | CN101952276A 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 01/19/2011 | CN101952275A Modulators for amyloid beta |
| 01/19/2011 | CN101952274A Non-nucleoside reverse transcriptase inhibitors |
| 01/19/2011 | CN101952273A Process for preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds |
| 01/19/2011 | CN101952272A 6-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 01/19/2011 | CN101952267A Cyclopropyl amine derivatives |
| 01/19/2011 | CN101952259A Benzodiazepine compound and pharmaceutical composition |
| 01/19/2011 | CN101952254A Isoquinoline modulators of ATP-binding cassette transporters |
| 01/19/2011 | CN101952251A Carbazole-based hole transport and /or electron blocking materials and /or host polymer materials |
| 01/19/2011 | CN101948462A Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 01/19/2011 | CN101072773B Pyrrole derivatives having CRTH2 receptor antagonist activity |
| 01/19/2011 | CN101052638B 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 01/19/2011 | CN101014578B Triazole derivative or salt thereof |
| 01/18/2011 | US7872141 Processes for the manufacture of a pyrrolidine-3,4-dicarboxamide derivative |
| 01/18/2011 | US7872140 contacting (S)-omeprazole freebase or its sodium/potassium salt with inorganic or organic acid salt of the barium (barium chloride, barium sulfate, barium oxalate, barium acetate) in a suitable solvent ( methanol)in presence of a base ( NaOH) to form (S)-omeprazole barium; helicobacter infections |
| 01/18/2011 | US7872138 aqueous solution of formaldehyde is added to a solution of 2-(3-methoxyphenyl)ethylamine in an aqueous HCl, cooling, basification with NaOH to form Bis(6-methoxy-3,4-dihydroisoquinolin-2(1H)-yl, adding concentrated HCl to form HCl salt; intermediates in the synthesis of pharmaceutical agents |
| 01/18/2011 | US7872137 coupling of N-3-hydroxypropyl-1-(R)-5'-methoxylaudanosinium chloride with (E)-4-octene-1,8-dioic acid dichloride, in a solvent(dichloromethane), to obtain raw mivacurium chloride, water extraction of raw product, treatment with amberlite" (tradename) absorbent resin, recovery of 97.5% pure product |
| 01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 01/18/2011 | US7872132 reacting 6-hydroxy-l-indanone with 1,4-dihalobutane in the presence of a base ( NaH), a solvent (methanol) to form a novel intermediate 6-(4-halo butoxy)-indan-1-one, reacting intermediate with 1-(2,3-clichlorophenyl)-piperazine to form another intermediate, reacting with sodim azide; aripiprazole |
| 01/18/2011 | US7872126 Tetrahydroquinoline derivatives and a process for preparing the same |
| 01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
| 01/18/2011 | US7872039 3-aminoindazoles |
| 01/18/2011 | US7872038 Low dosage oral veterinary medication; insects, arachnids and helminths |
| 01/18/2011 | US7872035 Angiotensin II antagonists |
| 01/18/2011 | US7872021 Liver X receptors (LXR) modulators such as 1-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-4-methoxy-N-(2-phenyl ethyl)-2,3-dihydro-1H-)indole-2-carboxamide, used for the treatment of atherosclerosis, dyslipidemia, obesity, diabetes, hypercholesterolemia, neurodegenerative diseases and inflammatory diseases |
| 01/18/2011 | US7872011 Inhibition of phosphoinositide 3-kinase β |
| 01/18/2011 | US7872010 Substituted diazabicycloalkane derivatives having affinity for nicotinic acetylcholine receptors |
| 01/18/2011 | US7872006 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-methoxy-3-[N-(1-azacycloheptyl)-carbamoyl]-1H-pyrazole, useful for treatment of nervous system disorders |
| 01/18/2011 | US7872002 Therapeutic pyrazoloquinoline derivatives |
| 01/18/2011 | CA2618636C Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands |
| 01/18/2011 | CA2573219C Hepatitis c inhibitor dipeptide analogs |
| 01/18/2011 | CA2568590C Propane-1,3-dione derivative or salt thereof useful as gnrh receptor antagonist |
| 01/18/2011 | CA2511984C Indazolamides with analgesic activity |
| 01/18/2011 | CA2511301C Acylsufonamide compounds as inhibitors of rna-dependent rna viral polymerase |
| 01/18/2011 | CA2500225C Pyrazole compounds |
| 01/18/2011 | CA2491895C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/18/2011 | CA2462374C Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage |
| 01/18/2011 | CA2436825C Process for the crystallization of (r)- or (s)-lansoprazole |
| 01/18/2011 | CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/18/2011 | CA2405304C Method for obtaining derivatives of [[(pyridil substituted)methyl]thio]benzimidazole |
| 01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |
| 01/13/2011 | WO2011005119A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| 01/13/2011 | WO2011004387A2 Process for the preparation of dexlansoprazole polymorphic forms |
| 01/13/2011 | WO2011004281A1 A process for the preparation of amorphous form of rabeprazole sodium |
| 01/13/2011 | WO2011004276A1 Hepatitis c virus inhibitors |
| 01/13/2011 | WO2011004132A1 Novel hsp90-inhibiting indole derivatives, compositions containing said derivatives, and use thereof |
| 01/13/2011 | WO2011004017A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use |
| 01/13/2011 | WO2011003684A1 Insecticidal compounds |
| 01/13/2011 | WO2011003365A1 Histone deacetylase inhibitors with branched structure synthesized through click chemistry |
| 01/13/2011 | WO2010056633A8 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 01/13/2011 | WO2010046780A3 Anti viral compounds |
| 01/13/2011 | WO2010012442A8 Insecticidal benzenedicarboxamide derivative |
| 01/13/2011 | US20110009637 Crystals of Dexlansoprazole |
| 01/13/2011 | US20110009636 Process for the preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds |
| 01/13/2011 | US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
| 01/13/2011 | US20110009620 4-Amino-5-cyanopyrimidine derivatives |
| 01/13/2011 | US20110009456 Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases |
| 01/13/2011 | US20110009454 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
| 01/13/2011 | US20110009448 Compound |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009440 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 01/13/2011 | US20110009437 Carboxamide-heteroaryl derivatives for the treatment of diabetes |
| 01/13/2011 | US20110009428 Novel androgens |
| 01/13/2011 | US20110009426 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists |
| 01/13/2011 | US20110009425 Tetrahydrothieno pyridines |
| 01/13/2011 | US20110009421 Compound having 6-membered aromatic ring |
| 01/13/2011 | US20110009420 Histamine H3 Receptor Ligands |
| 01/13/2011 | US20110009419 Enantiomers of 2'-Fluoralkyl-6-nitroquipazine as Serotonin Transporter Positron Emission Tomography Imaging Agents and Antidepressant Therapeutics |
| 01/13/2011 | US20110009418 Therapeutic agents useful for treating pain |
| 01/13/2011 | US20110009413 Cyclic triazo and diazo sodium channel blockers |
| 01/13/2011 | US20110009410 Apoptosis signal-regulating kinase inhibitors |
| 01/13/2011 | US20110009409 Dual-acting pyrazole antihypertensive agents |
| 01/13/2011 | US20110009407 Pyridinone antagonists of alpha-4 integrins |
| 01/13/2011 | US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009391 Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application |
| 01/13/2011 | US20110009389 Imidazole derivative, their production and use |
| 01/13/2011 | US20110009384 Fused ring compounds as partial agonists of ppar-gamma |
| 01/13/2011 | US20110009380 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 01/13/2011 | US20110009379 Indolinone compound |
| 01/13/2011 | US20110008373 Prodrugs of cc-1065 analogs |
| 01/13/2011 | US20110006295 Compounds having electroluminescent or electron transport properties |
| 01/13/2011 | US20110005947 Inhibitors of jak |
| 01/13/2011 | CA2767467A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use |
| 01/13/2011 | CA2767008A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| 01/13/2011 | CA2766343A1 Platelet-activating factor receptor antagonists |
| 01/13/2011 | CA2765012A1 Insecticidal compounds |
| 01/12/2011 | EP2272843A1 Quinoline compound |
| 01/12/2011 | EP2272841A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 01/12/2011 | EP2272834A1 Benzoyl amino heterocyclyl compounds as glucokinase (GLK) activators |
| 01/12/2011 | EP2272828A1 Compound for organic electroluminescent device and organic electroluminescent device using the same |